The standard panels do not include semaglutide
Considering the average body weight of the participants was nearly 230lb, this would translate to an average weight loss of over 40lb [9]
Payers should collaborate with plan sponsors, PBMs, manufacturers and providers to expand GLP-1 coverage: Payers have a key role in realizing GLP-1 cost savings as well as ensuring equitable, affordable access and quality of care by collaborating with PBMs, GLP-1 manufacturers and plan sponsors to expand GLP-1 coverage while driving down costs
Lu, J.H., Xu, Y., Wang, J.L., Singer, S.D
The Withdrawal Debate: Real or Myth
Given the lack of clear data on the subject, we selected a convenience sample of 42 patients